FDA NDC Directory · JSON-LD · Markdown

Adenosine

NDC 55150-193 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA205331
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsADENOSINE (90 mg/30mL)
Marketing started20171102
Package count2

External sources

Source: openFDA. Public-domain (CC0).